The missing mass of morality: A new fitpack design for hepatitis C prevention in sexual partnerships
MetadataShow full item record
In the West, most hepatitis C transmission occurs through the sharing of equipment used for injecting drugs, and most sharing occurs between sexual partners. Despite this, little is known about how injecting practice, including equipment use, is managed in these partnerships. This article draws on science studies theorist Bruno Latour’s work on technology and ethics (2002), and preliminary data collected fora research project on sexual partners who inject together, to illuminate these issues. Responsibility for avoiding transmission has long been conceived individually, as have measures intended to aid individuals in fulfilling this responsibility, such as the distribution of sterile injecting equipment. This individualising tendency has been criticised for inequitably responsibilising disadvantaged people. This article aims to exceed this individualising approach by proposing a different understanding of agency and a new mode of prevention. Rather than treating hepatitis C in conventional terms, as a bounded, ontologically stable object that pre-exists its encounter with individuals and the material objects they use in injecting, it formulates it as made in its enfolding with other phenomena, including social relationships and technological objects. In turn it sees transmission in new terms; as a question of social relationships and of object design. The article goes on to discuss a new Australian research project that takes this approach as its starting point, aiming to develop two key prevention innovations: (1) new messages aimed at partnerships rather than individuals, and (2) a new injecting pack or ‘fitpack’ that treats the partnership a sa primary unit of resourcing. The article concludes by considering the politics of this shift to an ethics of technology, social relationships and objects.
NOTICE: this is the author’s version of a work that was accepted for publication in International Journal of Drug Policy. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in International Journal of Drug Policy, Vol. 24, No. 3 (2013). DOI: 10.1016/j.drugpo.2013.03.009
Showing items related by title, author, creator and subject.
Hepatitis C prevention and convenience: why do people who inject drugs in sexual partnerships ‘run out’ of sterile equipment?Fraser, Suzanne; Rance, J.; Treloar, C. (2015)Rates of hepatitis C virus transmission among people who inject drugs in Australia remain high despite decades of prevention education. A key site of transmission is the sharing of injecting equipment within sexual ...
Harm reduction workers and the challenge of engaging couples who inject drugs in hepatitis C prevention.Treloar, C.; Rance, J.; Bryant, J.; Fraser, Suzanne (2016)AIMS: Despite injecting-equipment sharing between sexual partners leaving them at increased risk of hepatitis C (HCV), there is scant literature available to guide harm reduction workers in their encounters with couples ...
Fraser, Suzanne; Treloar, C.; Bryant, J.; Rhodes, T. (2014)Most hepatitis C transmission occurs through the sharing of equipment used for injecting drugs, and in many settings, the majority of equipment sharing occurs between sexual partners. Despite this, few health promotion ...